Search results for: 'Payer-Provider Connectivity Solutions North American 2023'

This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries are Mexico, Brazil, and Argentina. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, ...

This research service analyzes the funding scenario in radiation oncology industry sector and provides insights to investors for potential investments into promising technologies and offers strategic recommendations for firms for procuring funds. The study offers strategic analysis and insights on potential technologies worthy of investment and com...

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...